Search Results 1101-1110 of 18149 for monoclonal antibody

  1. A Study Of Long-acting Antibodies Alone And In Combinations For Moderate To Severe Ulcerative Colitis - Mayo Clinic

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...

  2. A Study To Evaluate ADP-A2M4 With Pembrolizumab To Treat Recurrent Or Metastatic Head And Neck Cancer - Mayo Clinic

    ... monoclonal antibody. History of autoimmune or immune mediated disease prior to enrollment. Subjects with hypothyroidism, diabetes, adrenal insufficiency or ...

  3. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  4. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  5. Novel SEQUEnced Immunotherapy With Anti-angiogenesis And Chemotherapy In Advanced GastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. - Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks ...

  6. Infectious Diseases Clinical Trials - Mayo Clinic Research

    ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19 Rochester, MN.

  7. Ublituximab In Autoantibody Positive Immune Mediated Necrotizing Myopathy - Mayo Clinic

    About this study. This is a multi-center, Phase 2 trial of ublituximab as first-line combination therapy in early, active autoantibody positive ...

  8. An Open-label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    An Open-label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or ...

  9. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

    Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E therapy ...

  10. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...